|
ovarian cancer |
24 |
|
cervical cancer |
21 |
|
chemotherapy |
21 |
|
human papillomavirus |
18 |
|
cervical screening |
16 |
|
female |
14 |
|
gestational trophoblastic neoplasia |
14 |
|
humans |
14 |
|
oncology |
14 |
|
cancer survivors |
12 |
|
chemoresistance |
12 |
|
choriocarcinoma |
12 |
|
cervical cancer screening |
11 |
|
gestational trophoblastic disease |
11 |
|
chinese |
10 |
|
adult |
8 |
|
animals |
8 |
|
blotting, western |
8 |
|
disease progression |
8 |
|
estrogen receptor alpha - genetics - metabolism |
8 |
|
hong kong |
8 |
|
hysterectomy |
8 |
|
promoter regions, genetic |
8 |
|
reverse transcriptase polymerase chain reaction |
8 |
|
rna, messenger - metabolism |
8 |
|
-depression |
7 |
|
analgesia |
7 |
|
cancer stem cells |
7 |
|
cancer-related distress |
7 |
|
cell line, tumor |
7 |
|
cervical intraepithelial neoplasia |
7 |
|
cervix uteri - virology |
7 |
|
cohort studies |
7 |
|
diagnostic biomarker |
7 |
|
distress |
7 |
|
dna, viral - genetics |
7 |
|
endometrial cancer |
7 |
|
epithelioid |
7 |
|
gene expression regulation, neoplastic |
7 |
|
gestational |
7 |
|
health economic analysis |
7 |
|
health-related quality of life |
7 |
|
hedgehog |
7 |
|
hpv vaccination |
7 |
|
iaspp |
7 |
|
illness perception |
7 |
|
immunotherapy |
7 |
|
insomnia |
7 |
|
long-term cancer survivors |
7 |
|
microrna |
7 |
|
middle aged |
7 |
|
morphine consumption |
7 |
|
occupation |
7 |
|
ovarian clear cell carcinoma |
7 |
|
placebo |
7 |
|
plk1 |
7 |
|
prognostic marker |
7 |
|
rct |
7 |
|
return to work |
7 |
|
self-sampling |
7 |
|
sensitivity and specificity |
7 |
|
serms |
7 |
|
sleep disturbance |
7 |
|
sleep quality |
7 |
|
sleep trajectory |
7 |
|
trophoblastic |
7 |
|
tumors |
7 |
|
work productivity |
7 |
|
adenocarcinoma - genetics - metabolism - pathology |
6 |
|
adolescent |
6 |
|
adult oncology |
6 |
|
anti-müllerian hormone |
6 |
|
apoptosis - drug effects - physiology |
6 |
|
asian continental ancestry group |
6 |
|
base sequence |
6 |
|
case-control studies |
6 |
|
cell adhesion - physiology |
6 |
|
cell line, transformed |
6 |
|
cell nucleus - metabolism |
6 |
|
cell proliferation - drug effects |
6 |
|
cervical cytology |
6 |
|
checkpoint inhibitor |
6 |
|
cin |
6 |
|
cisplatin - pharmacology |
6 |
|
colposcopy |
6 |
|
co‐testing |
6 |
|
dce-mri |
6 |
|
dna methylation |
6 |
|
drug resistance, neoplasm |
6 |
|
dual specificity phosphatase 6 - antagonists & inhibitors - genetics - metabolism |
6 |
|
endometrial carcinoma |
6 |
|
endometrial neoplasms - genetics - metabolism |
6 |
|
epigenesis, genetic |
6 |
|
estrogen receptors |
6 |
|
gli1 |
6 |
|
hedgehog proteins - genetics - metabolism |
6 |
|
high-grade tumor |
6 |
|
hpv testing |
6 |
|
hpv16/18 genotyping |
6 |
|
hydatidiform mole |
6 |
|
hydrogen peroxide - metabolism |
6 |
|
intravoxel incoherent motion |
6 |
|
ivim |
6 |
|
lymphadenectomy |
6 |
|
malignant ovarian germ cell tumors |
6 |
|
management |
6 |
|
mental health |
6 |
|
metallothionein - genetics - metabolism |
6 |
|
metallothionein 1e gene |
6 |
|
metastasis |
6 |
|
mice |
6 |
|
mir-141 |
6 |
|
mitogen-activated protein kinase 1 - antagonists & inhibitors - metabolism |
6 |
|
mitogen-activated protein kinase 3 - antagonists & inhibitors - metabolism |
6 |
|
molar pregnancy |
6 |
|
molecular sequence data |
6 |
|
neoplasm staging |
6 |
|
neoplasms |
6 |
|
nf-κb signaling |
6 |
|
nuclear proteins - genetics - metabolism |
6 |
|
ovarian neoplasms - drug therapy - genetics - pathology |
6 |
|
ovarian reserve |
6 |
|
oxidative stress - physiology |
6 |
|
papillomavirus infections - epidemiology - ethnology - virology |
6 |
|
pax1/sox1 methylation |
6 |
|
pd-l1 |
6 |
|
perfusion |
6 |
|
phosphorylation |
6 |
|
promoter hypermethylation |
6 |
|
rna, messenger - antagonists & inhibitors - genetics - metabolism |
6 |
|
signal transduction |
6 |
|
signal transduction - drug effects |
6 |
|
tak1 |
6 |
|
targeted therapy |
6 |
|
transcription factors - genetics - metabolism |
6 |
|
triage |
6 |
|
tumor cells, cultured |
6 |
|
tumor microenvironment |
6 |
|
tumourigenicity |
6 |
|
ubiquitin - metabolism |
6 |
|
uterine cervical neoplasms - genetics - metabolism - pathology |
6 |
|
zic2 |
6 |
|
advanced ovarian cancer |
5 |
|
aged |
5 |
|
animal experiment |
5 |
|
animal model |
5 |
|
anoikis resistance |
5 |
|
ascites |
5 |
|
breast cancer risk |
5 |
|
cancer |
5 |
|
cancer metabolism |
5 |
|
cancer prognosis |
5 |
|
cancer stem cell |
5 |
|
cancer survivorship |
5 |
|
carcinoma, squamous cell - ethnology - genetics - virology |
5 |
|
carcinosarcoma |
5 |
|
cd55 |
5 |
|
cd8+ t cell |
5 |
|
cell invasion and proliferation |
5 |
|
cervical intra-epithelial neoplasia |
5 |
|
cervical intraepithelial neoplasia - ethnology - genetics - virology |
5 |
|
china |
5 |
|
cytoreduction |
5 |
|
dichloroacetate dca |
5 |
|
enhanced recovery |
5 |
|
epithelial ovarian cancer |
5 |
|
fear of cancer recurrence |
5 |
|
gene expression profiling |
5 |
|
genes, viral - genetics |
5 |
|
genotype |
5 |
|
gynecological cancers |
5 |
|
hereditary breast cancer |
5 |
|
hexokinase ii |
5 |
|
hormonal treatment |
5 |
|
hpv‐e6 |
5 |
|
human papillomavirus 16 - genetics |
5 |
|
human papillomavirus 18 - genetics |
5 |
|
illness perceptions |
5 |
|
immunohistochemistry |
5 |
|
implementation study |
5 |
|
klf12 |
5 |
|
leiomyosarcoma |
5 |
|
measurement invariance |
5 |
|
mouse pachytene spermatocytes |
5 |
|
non-homologous xy desynapsis |
5 |
|
oncogenes - genetics |
5 |
|
optimism |
5 |
|
oxidoreductases |
5 |
|
p-p53 (ser15) |
5 |
|
palb2 mutation |
5 |
|
papillomavirus infections - ethnology - genetics |
5 |
|
patient-initiated follow-up |
5 |
|
pd-1 |
5 |
|
pdk1 |
5 |
|
pet/ct |
5 |
|
precancerous conditions - ethnology - genetics - virology |
5 |
|
prevalence |
5 |
|
prognosis |
5 |
|
pyruvate kinase |
5 |
|
quality of life |
5 |
|
random cervical biopsy |
5 |
|
reliability |
5 |
|
riot |
5 |
|
sp1 |
5 |
|
spdya |
5 |
|
squamous intraepithelial lesion |
5 |
|
standardized uptake value |
5 |
|
stemness |
5 |
|
stepped-care model |
5 |
|
supportive care needs |
5 |
|
survivin |
5 |
|
survivorship |
5 |
|
symptom distress |
5 |
|
symptom distress screening |
5 |
|
symptom management |
5 |
|
t cells |
5 |
|
telomeres |
5 |
|
tumor markers, biological - genetics |
5 |
|
unmet need |
5 |
|
uterine cervical neoplasms - ethnology - genetics - virology |
5 |
|
uterine neoplasms |
5 |
|
uterine sarcoma |
5 |
|
validity |
5 |
|
viral dna integration |
5 |
|
virus integration - genetics |
5 |
|
xy loop-axis organization |
5 |
|
adenocarcinoma - metabolism - pathology |
4 |
|
animal modelanimal tissue |
4 |
|
apoptosis regulatory proteins - genetics - metabolism |
4 |
|
autophagy |
4 |
|
autophagy and chemoresistance |
4 |
|
bd onclarity |
4 |
|
c-33 a cell line |
4 |
|
c-4-i cell line |
4 |
|
cancer aggressiveness |
4 |
|
cancer-associated fibroblasts |
4 |
|
cell migration and invasion |
4 |
|
chamoc regimen |
4 |
|
chemokines |
4 |
|
classification of proteins |
4 |
|
cost-effectiveness analysis |
4 |
|
cross-sectional studies |
4 |
|
cxcr2 |
4 |
|
death- associated protein kinase |
4 |
|
demethylating agents |
4 |
|
diagnostic procedure |
4 |
|
disease-free survival |
4 |
|
dna hypermethylation |
4 |
|
education |
4 |
|
educational status |
4 |
|
epigenetic |
4 |
|
estrogen receptor beta - genetics - metabolism |
4 |
|
fak/erk signaling |
4 |
|
follow‐up |
4 |
|
general gynaecology |
4 |
|
genital neoplasms, female - genetics |
4 |
|
grb7 |
4 |
|
gro-α |
4 |
|
gynaecological cancer |
4 |
|
health knowledge, attitudes, practice |
4 |
|
health surveys |
4 |
|
high-risk gestational trophoblastic disease |
4 |
|
hippo/yap1/pathway |
4 |
|
hk2 |
4 |
|
hpv |
4 |
|
hpv vaccine |
4 |
|
hpv vaccine perception |
4 |
|
hpv vaccine questionnaire |
4 |
|
hpv vaccine survey |
4 |
|
human papilloma virus (hpv) |
4 |
|
il-8 |
4 |
|
isothermal amplification |
4 |
|
mapk signaling |
4 |
|
medical imaging |
4 |
|
medicine |
4 |
|
methylation |
4 |
|
methylome profiling |
4 |
|
mir-193a-3p |
4 |
|
molecular diagnostic techniques - methods |
4 |
|
nanog |
4 |
|
neoplasia |
4 |
|
neoplastic stem cells - physiology |
4 |
|
nfκb signaling |
4 |
|
notch |
4 |
|
nurr1 |
4 |
|
omics |
4 |
|
ovarian carcinoma |
4 |
|
ovarian neoplasms - genetics - metabolism - pathology |
4 |
|
ovarian neoplasms - metabolism - pathology |
4 |
|
ovary - cytology - metabolism |
4 |
|
ovary - pathology |
4 |
|
papillomaviridae - classification - genetics - isolation and purification |
4 |
|
papillomaviridae - immunology |
4 |
|
papillomavirus infections - diagnosis - virology |
4 |
|
papillomavirus infections - prevention & control - virology |
4 |
|
papillomavirus vaccines |
4 |
|
peritoneal metastases |
4 |
|
pilot projects |
4 |
|
placental site |
4 |
|
placental-site tro phoblastic tumor |
4 |
|
population-based screening program |
4 |
|
pregnancy |
4 |
|
psychological well-being |
4 |
|
questionnaires |
4 |
|
radioresistance |
4 |
|
rna-binding proteins - genetics - metabolism |
4 |
|
self-renewal |
4 |
|
sentis hpv |
4 |
|
survival analysis |
4 |
|
tamoxifen |
4 |
|
therapeutic molecular target |
4 |
|
trophoblastic tumor |
4 |
|
tumor grading |
4 |
|
tumor-stroma interactions |
4 |
|
uterine cervical neoplasms - prevention & control - virology |
4 |
|
abdominal hysterectomy |
3 |
|
adenocarcinoma, clear cell - drug therapy - pathology - radiotherapy |
3 |
|
adenocarcinoma, clear cell - pathology - therapy |
3 |
|
adjuvants |
3 |
|
alphapapillomavirus - isolation and purification |
3 |
|
antineoplastic agents - therapeutic use |
3 |
|
antineoplastic combined chemotherapy protocols - administration & dosage |
3 |
|
antineoplastic combined chemotherapy protocols - adverse effects - therapeutic use |
3 |
|
anxiety - etiology |
3 |
|
apoptosis regulatory proteins - genetics - metabolism - physiology |
3 |
|
asian continental ancestry group - ethnology |
3 |
|
asian women |
3 |
|
attitude to health |
3 |
|
atypical cytology |
3 |
|
baby friendly community initiative |
3 |
|
bcl2a1 |
3 |
|
beliefs |
3 |
|
bfci |
3 |
|
biopsy, needle |
3 |
|
bitter melono |
3 |
|
brachytherapy - methods |
3 |
|
breastfeeding |
3 |
|
ca 125 |
3 |
|
cancer radiotherapy |
3 |
|
cancer screening |
3 |
|
carboplatin |
3 |
|
carcinogenesis |
3 |
|
cell cycle - physiology |
3 |
|
cell proliferation |
3 |
|
cell signaling |
3 |
|
cervix uteri - pathology - virology |
3 |
|
chemoirradiation |
3 |
|
chinese women |
3 |
|
choriocarcinoma, non-gestational - pathology - therapy |
3 |
|
clear cell adenocarcinoma |
3 |
|
clear cell carcinoma |
3 |
|
combination treatment |
3 |
|
combined modality therapy |
3 |
|
cyclind1 |
3 |
|
daidzein |
3 |
|
dendrimer |
3 |
|
drugs, chinese herbal - adverse effects - therapeutic use |
3 |
|
epithelioid trophoblastc tumour |
3 |
|
erb-041 |
3 |
|
fallopian tube patency tests - methods |
3 |
|
fgf9 |
3 |
|
follow-up |
3 |
|
follow-up studies |
3 |
|
gemcitabine |
3 |
|
genistein |
3 |
|
gynecologic oncology |
3 |
|
gynecologic surgical procedures |
3 |
|
hong kong - epidemiology |
3 |
|
human papillomavirus 16 |
3 |
|
human papillomavirus 18 |
3 |
|
hypoxia |
3 |
|
hysterosalpingography |
3 |
|
immune function |
3 |
|
immunologic |
3 |
|
immunology |
3 |
|
immunometabolism |
3 |
|
infertility, female - diagnosis |
3 |
|
intrinsic cell apoptosis |
3 |
|
knowledge |
3 |
|
laparoscopy |
3 |
|
leep |
3 |
|
lletz |
3 |
|
macrophage polarization |
3 |
|
map30 |
3 |
|
meta-analysis |
3 |
|
metabolism |
3 |
|
methotrexate |
3 |
|
mole |
3 |
|
monotherapy |
3 |
|
nanovector |
3 |
|
neoadjuvant chemotherapy |
3 |
|
neoplasm invasiveness - pathology |
3 |
|
nongestatational choriocarcinoma |
3 |
|
nr4a2 |
3 |
|
ovarian cancer and ascites |
3 |
|
ovarian cancer recurrence |
3 |
|
ovarian neoplasms - drug therapy - immunology |
3 |
|
ovarian neoplasms - pathology - therapy |
3 |
|
paclitaxel |
3 |
|
pain measurement |
3 |
|
papillomavirus infections - diagnosis - psychology |
3 |
|
papillomavirus infections - ethnology - prevention & control |
3 |
|
papillomavirus infections - ethnology - prevention & control - psychology |
3 |
|
papillomavirus vaccines - therapeutic use |
3 |
|
patient acceptance of health care |
3 |
|
patient acceptance of health care - ethnology |
3 |
|
patient satisfaction - ethnology |
3 |
|
peritoneal metastasis |
3 |
|
physical examination |
3 |
|
placental site trophoblastic tumour |
3 |
|
polyunsaturated fatty acids |
3 |
|
post lletz complications |
3 |
|
premetastatic niche |
3 |
|
prevention |
3 |
|
psychology |
3 |
|
rare diseases |
3 |
|
rhoa-yap1 signaling |
3 |
|
risk assessment |
3 |
|
rna-binding proteins - genetics - metabolism - physiology |
3 |
|
sox7 |
3 |
|
stress, psychological - etiology |
3 |
|
subfertility |
3 |
|
systematic review |
3 |
|
tam polarization |
3 |
|
tcf/lef-1 |
3 |
|
three-dimensional hysterosalpingo-contrast- sonography |
3 |
|
traditional chinese medicine |
3 |
|
treatment outcome |
3 |
|
tumor suppressor proteins - genetics - metabolism - physiology |
3 |
|
tumor-associated macrophages |
3 |
|
uterine cervical neoplasms |
3 |
|
uterine cervical neoplasms - drug therapy - pathology - radiotherapy |
3 |
|
uterine cervical neoplasms - ethnology - virology |
3 |
|
uterine cervical neoplasms - prevention and control - virology |
3 |
|
uterine cervical neoplasms - psychology |
3 |
|
uterine cervix cancer |
3 |
|
vaginal intraepithelial neoplasia |
3 |
|
varian cancer |
3 |
|
wnt/β-catenin |
3 |
|
women's health issues |
3 |
|
young adult |
3 |
|
3d ultrasound |
2 |
|
aapc |
2 |
|
angiography |
2 |
|
arteries - surgery |
2 |
|
attitudes |
2 |
|
bowel preparation |
2 |
|
cervical intraepithelial neoplasia - prevention & control - psychology |
2 |
|
chinese adolescent girls |
2 |
|
chorionic gonadotropin - analysis |
2 |
|
consumer health information - methods |
2 |
|
dalys |
2 |
|
embolization, therapeutic |
2 |
|
female cancers in child-bearing age |
2 |
|
ferritin |
2 |
|
gbd 2021 |
2 |
|
gestational diabetes |
2 |
|
gestational trophoblastic disease - complications - epidemiology |
2 |
|
gestational trophoblastic neoplasms |
2 |
|
gynecological cancer |
2 |
|
health personnel |
2 |
|
healthcare providers |
2 |
|
hemostatic techniques - utilization |
2 |
|
hpv education |
2 |
|
human papillomavirus testing |
2 |
|
hydatidiform mole - drug therapy - surgery |
2 |
|
impaired glucose tolerance |
2 |
|
incidence |
2 |
|
iron supplement |
2 |
|
ligation |
2 |
|
lymph node excision |
2 |
|
lymphocyst |
2 |
|
medical records |
2 |
|
needle holders |
2 |
|
ovarian neoplasms |
2 |
|
papillomavirus infections - prevention & control - psychology |
2 |
|
papillomavirus infections - prevention and control |
2 |
|
papillomavirus vaccines - administration & dosage |
2 |
|
pelvic lymphadenectomy |
2 |
|
placental-site trophoblastic tumour |
2 |
|
preoperative investigations |
2 |
|
preoperative preparation |
2 |
|
prophylactic antibiotics |
2 |
|
radiography, interventional |
2 |
|
relapse |
2 |
|
retrospective studies |
2 |
|
risk factor |
2 |
|
risk factors |
2 |
|
safety |
2 |
|
scalpel |
2 |
|
school-based health education |
2 |
|
scissors |
2 |
|
sexual behavior |
2 |
|
social stigma |
2 |
|
staging |
2 |
|
stigma |
2 |
|
surgery |
2 |
|
surgical instruments |
2 |
|
survival rate |
2 |
|
therapeutic embolization |
2 |
|
thromboprophylaxis |
2 |
|
tissue forceps |
2 |
|
treatment |
2 |
|
uterine bleeding |
2 |
|
uterine cervical neoplasms - ethnology - prevention and control - virology |
2 |
|
uterine hemorrhage - etiology - radiography - therapy |
2 |
|
uterine neoplasms - complications - epidemiology |
2 |
|
vaginal smears |
2 |
|
algorithms |
1 |
|
ca-125 antigen |
1 |
|
ca125 |
1 |
|
cesarean section - psychology |
1 |
|
circulating tumor cells |
1 |
|
circulating tumor dna |
1 |
|
clinical neuroendocrinology |
1 |
|
coelio-schauta procedure |
1 |
|
complications |
1 |
|
continence pouch |
1 |
|
cross-sectional study |
1 |
|
cytology and gyn pathology (3112 ) |
1 |
|
decision making |
1 |
|
delivery, obstetric - psychology |
1 |
|
diabetes mellitus |
1 |
|
emotions |
1 |
|
fathers - psychology |
1 |
|
fertility |
1 |
|
fetus |
1 |
|
gynecologic surgical procedures - methods |
1 |
|
haematocrit |
1 |
|
haemoglobin |
1 |
|
he4 |
1 |
|
health care organization |
1 |
|
health care personnel |
1 |
|
human papillomavirus (hpv) |
1 |
|
hyperthyrotropinemia |
1 |
|
hysterectomy - methods |
1 |
|
international collaboration |
1 |
|
laparoscopic pelvic lymph node dissection |
1 |
|
liquid biopsy |
1 |
|
locally advanced pelvic cancer |
1 |
|
male |
1 |
|
mortality |
1 |
|
neonatal neuroendocrinology |
1 |
|
neoplasms, glandular and epithelial - pathology - surgery |
1 |
|
nerve-sparing hysterectomy |
1 |
|
ovarian neoplasms - pathology - surgery |
1 |
|
palliative care |
1 |
|
palliative surgery |
1 |
|
papillomavirus infection |
1 |
|
parametrectomy |
1 |
|
pelvic exenteration |
1 |
|
pelvic malignancy |
1 |
|
pelvic mass |
1 |
|
placental ratio |
1 |
|
placental size |
1 |
|
prospective studies |
1 |
|
radical hysterectomy |
1 |
|
radical hystetectomy |
1 |
|
radical trachelectomy |
1 |
|
radiotherapy |
1 |
|
recurrence |
1 |
|
regression analysis |
1 |
|
roma |
1 |
|
sentinel lymph node biopsy |
1 |
|
sentinel lymph nodes |
1 |
|
surgical outcomes |
1 |
|
survival |
1 |
|
survival outcomes |
1 |
|
thyrotropin |
1 |
|
time trends |
1 |
|
total laparoscopic radical hysterectomy |
1 |
|
umbilical cord blood |
1 |
|
uterine cervical neoplasms - pathology - surgery |
1 |
|
vaccine supply constraint |
1 |
|
vaginal neoplasm |
1 |
